Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1979-7-16
|
pubmed:abstractText |
Piribedil, a dopamine agonist, was administered to 5 normal male subjects for two weeks. During the first two nights there was a reduction of about 17 p. 100 in paradoxical sleep (PS) and an increase of about 13 p. 100 in slow sleep II. There was a 15 p. 100 increase in PS during the third night. This increase is maintained for 8 nights in 3 subjects and 13 nights in 2 subjects. Other sleep parameters were not altered. Piribedil appears to give the impression of satisfactory sleep by reducing the subjective period before falling asleep. Piribedil also diminishes the remembrance of dreams.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0370-4475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
326-34
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:220684-Adult,
pubmed-meshheading:220684-Dreams,
pubmed-meshheading:220684-Humans,
pubmed-meshheading:220684-Male,
pubmed-meshheading:220684-Piperazines,
pubmed-meshheading:220684-Piribedil,
pubmed-meshheading:220684-Sleep,
pubmed-meshheading:220684-Sleep, REM,
pubmed-meshheading:220684-Sleep Stages
|
pubmed:year |
1978
|
pubmed:articleTitle |
[Effect of piribedil on nocturnal sleep (author's transl)].
|
pubmed:publicationType |
Journal Article,
English Abstract
|